Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-10-25
Target enrollment:
Participant gender:
Summary
The Phase I part of the study will identify the doses of pazopanib and paclitaxel that can be
administered safely in combination. The Phase II part of the study will not be progressed as
documented in Protocol Amendment 01.